Diagnostic and therapeutic advances in growth hormone insensitivity

Endocrinology and Metabolism Clinics of North America

Volumn 34, Issue 3, 2005, Pages 581-595

  David, Alessia ^a   Metherell, Louise A ^a   Clark, Adrian J L ^a   Camacho Hübner, Cecilia ^b   Savage, Martin O ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HORMONE BINDING PROTEIN; IODINE 125; RECOMBINANT GROWTH HORMONE; RECOMBINANT HUMAN INSULIN; RECOMBINANT SOMATOMEDIN C; SIGNAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AIRWAY OBSTRUCTION; ANOREXIA; BODY FAT; BODY MASS; BRAIN PSEUDOTUMOR; CONVULSION; DIMERIZATION; FACIAL NERVE PARALYSIS; FACIES; GENE MUTATION; GROWTH HORMONE INSENSITIVITY; HAIR GROWTH; HEADACHE; HORMONE RESISTANCE; HUMAN; HYPOGLYCEMIA; IDIOPATHIC DISEASE; INJECTION SITE REACTION; KIDNEY SIZE; LARON SYNDROME; LIPOHYPERTROPHY; PAPILLEDEMA; PRIORITY JOURNAL; REVIEW; SHORT STATURE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPLEEN SIZE; TONSILLECTOMY; TREATMENT OUTCOME;

DRUG THERAPY, COMBINATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; MUTATION; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS;

EID: 23444434185     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2005.04.009     Document Type: Review

References (84)

1. Z. Laron Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome) J Pediatr Endocrinol Metab 12 1 Suppl 1999 231 249
2. P.D. Gluckman, A.J. Gunn, A. Wray for the International Board of the Kabi Pharmacia International Growth Study Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure J Pediatr 121 6 1992 920 923
3. K.A. Woods, C. Camacho-Hubner, and M.O. Savage Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene N Engl J Med 335 18 1996 1363 1367
4. L.K. Bachrach, R. Marcus, and S.M. Ott Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency J Bone Miner Res 13 3 1998 415 421
5. C.A. Benbassat, V. Eshed, and M. Kamjin Are adult patients with Laron syndrome osteopenic? a comparison between dual-energy X-ray absorptiometry and volumetric bone densities J Clin Endocrinol Metab 88 10 2003 4586 4589
6. I. Arad, and Z. Laron Standards for upper/lower body segment/sitting height-subischial leg length, from birth to 18 years in girls and boys Proceedings of the 1st International Congress of Auxology. Rome, Italy, 1977 1979 Centro Auxologia Italiano di Piancavallo Milan (Italy) 159 164
7. C.P. Burren, K.A. Woods, and S.J. Rose Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome Horm Res 55 3 2001 125 130
8. M.O. Savage, W.F. Blum, and M.B. Ranke Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome) J Clin Endocrinol Metab 77 6 1993 1465 1471
9. Z. Laron, R. Sarel, and A. Pertzelan Puberty in Laron type dwarfism Eur J Pediatr 134 1 1980 79 83
10. Z. Laron, Y. Avitzur, and B. Klinger Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment Metabolism 44 4 Suppl 1995 S113 S118
11. K.A. Woods, C. Camacho-Hubner, and D. Barter Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature Acta Paediatr Suppl 423 1997 39 45
12. Z. Laron, W. Blum, and P. Chatelain Classification of growth hormone insensitivity syndrome J Pediatr 122 2 1993 241
13. Z. Laron, A. Pertzelan, and S. Mannheimer Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr J Med Sci 2 2 1966 152 155
14. M.A. Berg, R. Peoples, and L. Perez-Jurado Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorian E180 splice mutation in an oriental Jewish patient Acta Paediatr Suppl 399 1994 112 114
15. G.B. Schaefer, A.L. Rosenbloom, and J. Guevara-Aguirre Facial morphometry of Ecuadorian patients with growth hormone receptor deficiency/Laron syndrome J Med Genet 31 8 1994 635 639
16. T.J. Merimee, J. Hall, and D. Rabinowitz An unusual variety of endocrine dwarfism: subresponsiveness to growth hormone in a sexually mature dwarf Lancet 2 7561 1968 191 193
17. Z. Laron Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003 J Clin Endocrinol Metab 89 3 2004 1031 1044
18. K.A. Woods, and M.O. Savage Laron syndrome: typical and atypical forms Baillieres Clin Endocrinol Metab 10 3 1996 371 387
19. R. Eshet, Z. Laron, and A. Pertzelan Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism Isr J Med Sci 20 1 1984 8 11
20. D.W. Leung, S.A. Spencer, and G. Cachianes Growth hormone receptor and serum binding protein: purification, cloning and expression Nature 330 6148 1987 537 543
21. K.A. Woods, F. Dastot, and M.A. Preece Phenotype: genotype relationships in growth hormone insensitivity syndrome J Clin Endocrinol Metab 82 11 1997 3529 3535
22. M. Ballesteros, K.C. Leung, and R.J. Ross Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues J Clin Endocrinol Metab 85 8 2000 2865 2871
23. J.F. Bazan Structural design and molecular evolution of a cytokine receptor superfamily Proc Natl Acad Sci USA 87 18 1990 6934 6938
24. P.J. Godowski, D.W. Leung, and L.R. Meacham Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism Proc Natl Acad Sci USA 86 20 1989 8083 8087
25. B.C. Cunningham, M. Ultsch, and A.M. De Vos Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule Science 254 5033 1991 821 825
26. A.M. de Vos, M. Ultsch, and A.A. Kossiakoff Human growth hormone and extracellular domain of its receptor: crystal structure of the complex Science 255 5042 1992 306 312
27. L.S. Argetsinger, G.S. Campbell, and X. Yang Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase Cell 74 2 1993 237 244
28. H.W. Davey, R.J. Wilkins, and D.J. Waxman STAT5 signaling in sexually dimorphic gene expression and growth patterns Am J Hum Genet 65 4 1999 959 965
29. H.K. Choi, and D.J. Waxman Pulsatility of growth hormone (GH) signaling in liver cells: role of the JAK-STAT5b pathway in GH action Growth Horm IGF Res 10 Suppl B 2000 S1 S8
30. Z. Laron, and B. Klinger Laron syndrome: clinical features, molecular pathology and treatment Horm Res 42 1994 198 202
31. A. Besson, S. Salemi, and A. Eble Primary GH insensitivity (Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I Eur J Endocrinol 150 5 2004 635 642
32. L.R. Meacham, M.R. Brown, and T.L. Murphy Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome J Clin Endocrinol Metab 77 5 1993 1379 1383
33. J.M. Gastier, M.A. Berg, and P. Vesterhus Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome Hum Mutat 16 4 2000 323 333
34. M.L. Sobrier, F. Dastot, and P. Duquesnoy Nine novel growth hormone receptor gene mutations in patients with Laron syndrome J Clin Endocrinol Metab 82 2 1997 435 437
35. M.A. Berg, J. Argente, and S. Chernausek Diverse growth hormone receptor gene mutations in Laron syndrome Am J Hum Genet 52 5 1993 998 1005
36. S. Amselem, M.L. Sobrier, and P. Duquesnoy Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism J Clin Invest 87 3 1991 1098 1102
37. O. Shevah, P. Borrelli, and M. Rubinstein Identification of two novel mutations in the human growth hormone receptor gene J Endocrinol Invest 26 7 2003 604 608
38. A.D. Goddard, R. Covello, S.M. Luoh for the Growth Hormone Insensitivity Study Group Mutations of the growth hormone receptor in children with idiopathic short stature N Engl J Med 333 17 1995 1093 1098
39. S. Amselem, P. Duquesnoy, and B. Duriez Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome Hum Mol Genet 2 4 1993 355 359
40. H. Kaji, O. Nose, and H. Tajiri Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome J Clin Endocrinol Metab 82 11 1997 3705 3709
41. P. Duquesnoy, M.L. Sobrier, and B. Duriez A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization EMBO J 13 6 1994 1386 1395
42. K.A. Woods, N.C. Fraser, and M.C. Postel-Vinay A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein J Clin Endocrinol Metab 81 5 1996 1686 1690
43. A. Silbergeld, F. Dastot, and B. Klinger Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree J Pediatr Endocrinol Metab 10 3 1997 265 274
44. R.M. Ayling, R. Ross, and P. Towner A dominant-negative mutation of the growth hormone receptor causes familial short stature Nat Genet 16 1 1997 13 14
45. K. Iida, Y. Takahashi, and H. Kaji Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain J Clin Endocrinol Metab 83 2 1998 531 537
46. L.A. Metherell, S.A. Akker, and P.B. Munroe Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity Am J Hum Genet 69 3 2001 641 646
47. P. Saenger Partial growth hormone insensitivity: idiopathic short stature is not always idiopathic Acta Paediatr Suppl 88 428 1999 194 198
48. A. Milward, L. Metherell, and M. Maamra Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction J Clin Endocrinol Metab 89 3 2004 1259 1266
49. A.D. Goddard, P. Dowd, and S. Chernausek Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature J Pediatr 131 Suppl 1 1997 S51 S55
50. J.E. Sanchez, E. Perera, and L. Baumbach Growth hormone receptor mutations in children with idiopathic short stature J Clin Endocrinol Metab 83 11 1998 4079 4083
51. K. Kou, R. Lajara, and P. Rotwein Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome J Clin Endocrinol Metab 76 1 1993 54 59
52. K. Iida, Y. Takahashi, and H. Kaji The C422F mutation of the growth hormone receptor gene is not responsible for short stature J Clin Endocrinol Metab 84 11 1999 4214 4219
53. S. Chujo, H. Kaji, and Y. Takahashi No correlation of growth hormone receptor gene mutation P561T with body height Eur J Endocrinol 134 5 1996 560 562
54. T. Sakurai, K. Iida, and Y. Takahashi A novel heterozygous T51I mutation of growth hormone receptor is not associated with short stature Growth Horm IGF Res 12 6 2002 411 417
55. M. Salerno, B. Balestrieri, and E. Matrecano Abnormal GH receptor signaling in children with idiopathic short stature J Clin Endocrinol Metab 86 8 2001 3882 3888
56. C.M. Silva, M.T. Kloth, and A.J. Whatmore GH and epidermal growth factor signaling in normal and Laron syndrome fibroblasts Endocrinology 143 7 2002 2610 2617
57. E.M. Kofoed, V. Hwa, and B. Little Growth hormone insensitivity associated with a STAT5b mutation N Engl J Med 349 12 2003 1139 1147
58. Z. Laron, B. Erster, and B. Klinger Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism Lancet 19 2 1988 1170 1172
59. J.L. Walker, M. Ginalska-Malinovska, and T.E. Romer Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism) N Engl J Med 324 1991 1483 1488
60. A. Grahnen, K. Kastrup, and U. Heinrich Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency Acta Paediatr 391 Suppl 1993 S9 S13
61. A.M. Cotterill, C. Camacho-Hübner, and J.M.P. Holly The effect of recombinant human insulin-like growth factor-i treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome) Clin Endocrinol 39 1993 119 122
62. Z. Laron, S. Anin, and Y. Klipper-Aurbach Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism Lancet 339 1992 1258 1261
63. J. Guevara-Aguirre, O. Vasconez, and V. Martinez A randomized, double-blind, placebo controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency J Clin Endocrinol Metab 80 1995 1393 1398
64. M.B. Ranke, M.O. Savage, and P.G. Chatelain Insulin-like growth factor (IGF)-I improves height in growth hormone insensitivity: two year's results Horm Res 44 1995 253 264
65. P.F. Backeljauw, L.E. Underwood for the GHIS Collaborative Group Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome: a clinical research center study J Clin Endocrinol Metab 81 1996 3312 3317
66. M.B. Ranke, M.O. Savage, and P.G. Chatelain Treatment of growth hormone insensitivity syndrome with insulin-like growth factor-I: long-term results of the European multicentre study Horm Res 51 1999 128 134
67. P.F. Backeljauw, L.E. Underwood for the GHIS Collaborative Group Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study J Clin Endocrinol Metab 86 2001 1504 1510
68. J. Guevara-Aguirre, A.L. Rosenbloom, and O. Vasconez Two year treatment of growth hormone receptor deficiency (GHRD) with recombinant insulin-like growth factor-I in 22 children: comparison of two dosage levels and to GH treated GH deficiency J Clin Endocrinol Metab 82 1997 629 633
69. M.B. Ranke Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I). Growth hormone resistance Bailliere's Clin Endocrinol Metab 10 1996 401 410
70. C. Azcona, M.A. Preece, and S.J. Rose Growth response to rhIGF-I 80 μg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype Clin Endocrinol 5 1999 787 792
71. L.M. Carlsson, K.M. Attie, and P.G. Compton Reduced concentration of serum growth hormone binding protein in children with idiopathic short stature J Clin Endocrinol Metab 78 1994 1325 1330
72. K.M. Attie, L.M. Carlsson, A.C. Rundle for the National Cooperative Growth Study Evidence for partial growth hormone insensitivity among patients with idiopathic short stature J Pediatr 127 1995 244 250
73. A.D. Rogol, S.L. Blethen, J.P. Sy for the National Cooperative Growth Study Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over stimulation testing in predicting the linear growth response to GH therapy? Clin Endocrinol 58 2003 229 237
74. C.E. Brain, and M.O. Savage Disturbance of growth and pubertal development in chronic inflammatory bowel disease J.A. Walker-Smith T.T. MacDonald Chronic inflammatory bowel disease in childhood 1994 Elsevier 83 100
75. R.M. Beattie, C. Camacho-Hübner, and S. Wacharasindhu Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease Clin Endocrinol 48 1998 483 489
76. M.E. Street, G. de'Angelis, and C. Camacho-Hubner Relationships between serum IGF-I, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease Horm Res 61 4 2004 159 164
77. F. De Benedetti, T. Alonzi, and A. Moretta Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: a model for stunted growth in children with chronic inflammation J Clin Invest 99 1997 4643 4650
78. U.M. Davies, J. Jones, and J. Reeve Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin Arthritis Rheum 40 1997 332 340
79. R. Sheridan Modulation of types I and II acute phase reactants with insulin-like growth factor-I/binding protein 3 complex in severely burned children Crit Care Med 30 1 2002 255 257
80. S. Boonen, C. Rosen, and R. Bouillon Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double blind, placebo-controlled pilot study J Clin Endocrinol Metab 87 4 2002 1593 1599
81. D.R. Clemmons, A.C. Moses, and M.J. McKay The combination of insulin-like growth factor I and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type I diabetes: evidence for in vivo biological activity J Clin Endocrinol Metab 85 4 2000 1518 1524
82. Rogol AD, Jacobson W, Smith A, et al. A double-blind, randomized, placebo-controlled, study to determine the dose response profile of rhIGF-I/rhIGFBP-3 in subjects with type 2 diabetes mellitus requiring insulin therapy [poster]. Presented at the 61st Scientific Session of the American Diabetes Association Meeting. San Francisco, California, June 2002.
83. T. Saukkonen, R. Amin, and R.M. Williams Effects of combined recombinant human insulin-like growth factor-I/insulin-like growth factor binding protein 3 on growth hormone secretion and insulin sensitivity in adolescent with type I diabetes [abstract] Horm Res 60 2 Suppl 2003 14
84. C. Camacho-Hübner, H. Storr, and F. Miraki-Moud Recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex administered to patients with growth hormone insensitivity syndrome [abstract] Horm Res 60 2 Suppl 2003 15